These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20206869)

  • 21. [Dyslipidemia, diabetes and cardiovascular disease].
    Hansen CN; Jensen TJ; Borch-Johnsen K
    Ugeskr Laeger; 2000 Aug; 162(33):4367-70. PubMed ID: 10962957
    [No Abstract]   [Full Text] [Related]  

  • 22. Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open-label randomized pilot study.
    Faglia E; Manuela M; Antonella Q; Michela G; Vincenzo C; Maurizio C; Roberto M; Alberto M
    Am Heart J; 2005 Feb; 149(2):e1-6. PubMed ID: 15846252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes as a 'cardiovascular disease equivalent': implications for treatment.
    Laakso M
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):682-3. PubMed ID: 18797431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for nephropathy and cardiovascular disease in diabetic Northern Minnesota American Indians.
    Hirata-Dulas CA; Rith-Najarian SJ; McIntyre MC; Ross C; Dahl DC; Keane WF; Kasiske BL
    Clin Nephrol; 1996 Aug; 46(2):92-8. PubMed ID: 8869785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-type natriuretic peptide as an alternative way of assessing total cardiovascular risk in patients with diabetes mellitus.
    Dawson A; Jeyaseelan S; Morris AD; Struthers AD
    Am J Cardiol; 2005 Oct; 96(7):933-4. PubMed ID: 16188519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium antagonists and cardiovascular risk in patients with hypertension and Type 2 diabetes mellitus: evidence from the PIUMA Study. Progetto Ipertensione Umbria Monitoraggio Ambulatoriale.
    Verdecchia P; Schillaci G; Reboldi G; Borgioni C; Ciucci A; Porcellati C
    Diabetes Nutr Metab; 1999 Aug; 12(4):292-9. PubMed ID: 10782756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal diabetes management during medical weight loss for cardiovascular risk reduction.
    Nori Janosz KE; Miller WM; Odom J; Lillystone M; McCullough PA
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):761-75. PubMed ID: 16076284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular manifestations of insulin resistance.
    Chahwala V; Arora R
    Am J Ther; 2009; 16(5):e14-28. PubMed ID: 19114874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiologist's role in improving glucose control and global cardiovascular risk in patients with type 2 diabetes mellitus.
    Gotto AM
    Am J Cardiol; 2007 Feb; 99(4A):3B-5B. PubMed ID: 17307053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early intensive cardiovascular risk management in young people with type 2 diabetes.
    Song SH; Gray TA
    Diabetes Res Clin Pract; 2011 Jun; 92(3):e70-2. PubMed ID: 21420751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The diabetes-heart disease connection and what it means for you. Understand the interactions between these two conditions.
    Harv Heart Lett; 2014 Apr; 24(8):5. PubMed ID: 25108931
    [No Abstract]   [Full Text] [Related]  

  • 32. [Iatrogenic hypoglycemia and cardiovascular risk in type 2 diabetes].
    Consoli A; Di Fulvio P
    G Ital Cardiol (Rome); 2012 Dec; 13(12):787-92. PubMed ID: 23196681
    [No Abstract]   [Full Text] [Related]  

  • 33. [What do type II diabetics know about cardiovascular risk factors? Relationship with the level of control of these factors].
    Navarro Oliver AF; Martínez Navarro A; Martínez Navarro MA; Leal Hernández M
    Semergen; 2014 Sep; 40(6):352-3. PubMed ID: 25016943
    [No Abstract]   [Full Text] [Related]  

  • 34. [Coronary heart disease morbidity in NIDDM].
    Kuusisto J; Lehto S; Laakso M
    Duodecim; 1996; 112(21):1965-6. PubMed ID: 10605197
    [No Abstract]   [Full Text] [Related]  

  • 35. Diabetes and coronary risk equivalency: what does it mean?
    Grundy SM
    Diabetes Care; 2006 Feb; 29(2):457-60. PubMed ID: 16443907
    [No Abstract]   [Full Text] [Related]  

  • 36. Are postprandial triglyceride and insulin abnormalities neglected cardiovascular risk factors in type 2 diabetes?
    Golay A
    Eur J Clin Invest; 2000 Aug; 30 Suppl 2():12-8. PubMed ID: 10975049
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardio-diabetes: special considerations for the patient with diabetes and cardiovascular disease. Introduction.
    Davidson MH
    Am J Cardiol; 2012 Nov; 110(9 Suppl):1B-3B. PubMed ID: 23062563
    [No Abstract]   [Full Text] [Related]  

  • 38. Issues in management: the role of insulin in cardiovascular outcomes.
    Haffner SM
    Diabetes Metab Rev; 1998 Sep; 14 Suppl 1():S51-6. PubMed ID: 9816488
    [No Abstract]   [Full Text] [Related]  

  • 39. Introductory remarks for the First Interamerican Congress of Diabetes Maracaibo-Venezuela, July 2010.
    Velasco M; Israili Z; Bermúdez V
    Am J Ther; 2013; 20(4):347-8. PubMed ID: 23838632
    [No Abstract]   [Full Text] [Related]  

  • 40. [Diabetes... and dialogue: shock and happiness].
    Devulder B
    Rev Med Interne; 2004 Oct; 25 Spec No 2():1-2. PubMed ID: 15641502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.